Aduro Biotech Europe Overview

  • Founded
  • 2011

  • Status
  • Acquired/​Merged

  • Employees
  • 23

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $64.6M

Aduro Biotech Europe General Information


Provider of therapeutic services for cancer. The company specializes in the development of oncology antibodies for the treatment of cancer.

Contact Information

Formerly Known As
Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Other Healthcare Services
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Discovery
Primary Office
  • Pivot Park, RX1101
  • Molenweg 79
  • 5349 AC OSS
  • Netherlands

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aduro Biotech Europe Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 30-Oct-2015 $64.6M 000.00 Completed Generating Revenue
1. Early Stage VC Completed Startup
To view Aduro Biotech Europe’s complete valuation and funding history, request access »

Aduro Biotech Europe Executive Team (3)

Name Title Board Seat Contact Info
Hans Van Eenennaam Ph.D Co-Founder & Chief Operational Officer
Andrea Van Elsas Ph.D Co-Founder & Chief Scientific Officer
You’re viewing 2 of 3 executive team members. Get the full list »

Aduro Biotech Europe Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aduro Biotech Europe Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Agri Food Health Innovation Centre Venture Capital Minority 000 0000 000000 0
Brabant Life Sciences Seed Fund Venture Capital Minority 000 0000 000000 0
Brabantse Ontwikkelings Maatschappij Growth/Expansion Minority 000 0000 000000 0
To view Aduro Biotech Europe’s complete investors history, request access »